This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: CREE DIS MDRX TWX WLP

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Cigna (CI) was downgraded at Jefferies to hold from buy. Valuation call, as the stock is up 70% since July, Jefferies said. $75 price target.

Cree (CREE) was downgraded at Sterne Agee to neutral. $59 price target. Estimates also cut, following negative checks in the lighting business, Sterne Agee said.

Disney (DIS) was initiated with an outperform rating at BMO Capital. $76 price target. Company deserves a premium valuation, BMO Capital said.

Fusion-io (FIO) was upgraded at UBS to buy from neutral. The stock price decline and strong flash demand overcompensate for the near-term risks, UBS said. Price target goes to $19.


Blackhawk (HAWK) was initiated with a buy rating at Goldman Sachs. $28 price target. Company should see improved store productivity and growth through new products, Goldman said.

Allscripts Healthcare Solutions (MDRX) was upgraded at Citigroup to buy from neutral. Next-generation solutions will capitalize on the population health opportunity, said Citigroup. Price target goes to $18.

Monster Beverage (MNST) was initiated with an overweight rating at Morgan Stanley. $65 price target. Valuation does not fully reflect strong growth potential, Morgan Stanley said.


Melco Crown (MPEL) was downgraded at UBS to neutral from buy. Operations and liquidity have improved recently, with these events now priced in, UBS said. Price target goes to $26.

Solarcity (SCTY) was downgraded at Credit Suisse to neutral from outperform. Valuation call, based on a $28 price target, Credit Suisse said.

Time Warner (TWX) was initiated with a market-perform rating at BMO Capital. Valuation call, based on a $64 price target, BMO Capital said.

Vivus was downgraded at Lazard Capital Markets to neutral from buy. The window of opportunity is closing for Qsymia in the obesity market, Lazard Capital Markets said.


Wellpoint (WLP) was upgraded at Jefferies to buy from hold. $92 price target. Buybacks will help boost growth, Jefferies said.

STOCK COMMENTS/EPS CHANGES

Mosaic (MOS) price target and estimates were updated at UBS. Estimates were adjusted after announcing plans to repurchase shares and raise its dividend, UBS said. Price target was raised to $68.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,113.54 +61.81 0.36%
S&P 500 1,983.53 +9.90 0.50%
NASDAQ 4,456.0160 +31.3120 0.71%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs